A year ago, Flora Growth Chief Executive Damian Lopez had just spent a chunk of his company's seed capital buying a Colombian cannabis producer, and was fighting his way through the legal and financial hurdles that have made development of the industry such a challenge over the past decade.
Lopez is far from alone. U.S.-based dispensary business Gage Cannabis announced two weeks ago it would seek to list in the new year, while synthetic cannabinoid maker BioMedican has also laid out plans to go public in the first half of 2021. But even if President Donald Trump wins a second term, changing views on marijuana laws among voters and lawmakers have brightened the outlook for the industry, CEOs and analysts said.Voters in five states, including densely-populated New Jersey and rapidly-growing Arizona, are expected to back measures on Nov. 3 that would allow recreational use of marijuana."We believe the November elections could drive meaningful upside for the U.S.
“Each election cycle cannabis comes closer to federal acceptance, and this election is pivotal to those goals,” said Cynthia Salarizadeh, founder and president of House of Saka, a cannabis-infused beverages business.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: BusinessTimes - 🏆 15. / 51 Weiterlesen »